Pulmonary Arterial Hypertension Treatment Market, Poised to Surpass a Noteworthy US$ 6.6 Billion by 2028-FMI Projection

The pulmonary arterial hypertension (PAH) treatment industry stands as a beacon of hope for individuals grappling with this rare but serious condition that affects the heart and lungs. PAH involves abnormally high blood pressure in the arteries that connect the heart and lungs, leading to reduced blood flow and strain on the heart. The treatment landscape for …